Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7


Amplification of HER2 and TOP2A and deletion of TOP2A genes in a series of Taiwanese breast cancer.

Chen JR, Chien HP, Chen KS, Hwang CC, Chen HY, Yeh KY, Hsieh TY, Chang LC, Hsu YC, Lu RJ, Hua CC.

Medicine (Baltimore). 2017 Jan;96(2):e5582. doi: 10.1097/MD.0000000000005582.


Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate.

Holst F.

World J Clin Oncol. 2016 Apr 10;7(2):160-73. doi: 10.5306/wjco.v7.i2.160. Review.


Androgen receptor as a targeted therapy for breast cancer.

Garay JP, Park BH.

Am J Cancer Res. 2012;2(4):434-45. Epub 2012 Jun 28.


Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplification.

Kornegoor R, Moelans CB, Verschuur-Maes AH, Hogenes MC, de Bruin PC, Oudejans JJ, Marchionni L, van Diest PJ.

Breast Cancer Res Treat. 2012 Aug;135(1):49-58. doi: 10.1007/s10549-012-2051-3. Epub 2012 Apr 13.


The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation.

Garay JP, Karakas B, Abukhdeir AM, Cosgrove DP, Gustin JP, Higgins MJ, Konishi H, Konishi Y, Lauring J, Mohseni M, Wang GM, Jelovac D, Weeraratna A, Sherman Baust CA, Morin PJ, Toubaji A, Meeker A, De Marzo AM, Lewis G, Subhawong A, Argani P, Park BH.

Breast Cancer Res. 2012 Feb 9;14(1):R27.


Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial.

Ejlertsen B, Aldridge J, Nielsen KV, Regan MM, Henriksen KL, Lykkesfeldt AE, Müller S, Gelber RD, Price KN, Rasmussen BB, Viale G, Mouridsen H; Danish Breast Cancer Cooperative Group; BIG 1-98 Collaborative Group; International Breast Cancer Study Group.

Ann Oncol. 2012 May;23(5):1138-44. doi: 10.1093/annonc/mdr438. Epub 2011 Oct 10.


ESR1 amplification is rare in breast cancer and is associated with high grade and high proliferation: a multiplex ligation-dependent probe amplification study.

Moelans CB, Monsuur HN, de Pinth JH, Radersma RD, de Weger RA, van Diest PJ.

Cell Oncol (Dordr). 2011 Oct;34(5):489-94. doi: 10.1007/s13402-011-0045-5. Epub 2011 May 4. Erratum in: Cell Oncol (Dordr). 2011 Oct;34(5):509-10.

Supplemental Content

Support Center